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1 Abstract
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Genome Wide Association Studies (GWAS) and eQTL analyses have produced a large and growing
number of genetic associations linked to a wide range of human phenotypes. As of 2013, there
were more than 11,000 SNPs associated with a trait as reported in the NHGRI GWAS Catalog.
However, interpreting the functional roles played by these SNPs remains a challenge. Here we
describe an approach that uses the inherent bipartite structure of eQTL networks to place SNPs
into a functional context.
Using genotyping and gene expression data from 163 lung tissue samples in a study of Chronic
Obstructive Pulmonary Disease (COPD) we calculated eQTL associations between SNPs and genes
and cast significant associations (FDR < 0.1) as links in a bipartite network. To our surprise,
we discovered that the highly-connected “hub” SNPs within the network were devoid of disease-
associations. However, within the network we identified 35 highly modular communities, which
comprise groups of SNPs associated with groups of genes; 13 of these communities were signifi-
cantly enriched for distinct biological functions (P < 5× 10−4) including COPD-related functions.
Further, we found that GWAS-significant SNPs were enriched at the cores of these communities,
including previously identified GWAS associations for COPD, asthma, and pulmonary function,
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among others. These results speak to our intuition: rather than single SNPs influencing single
genes, we see groups of SNPs associated with the expression of families of functionally related
genes and that disease SNPs are associated with the perturbation of those functions. These meth-
ods are not limited in their application to COPD and can be used in the analysis of a wide variety
of disease processes and other phenotypic traits.
2 Introduction
Genome Wide Association Studies (GWAS) have created new opportunities to understand the
genetic factors that influence complex traits. Excepting highly-penetrant Mendelian disorders, the
majority of genetic associations seem to be driven by many factors, each of which has a relatively
small effect. In a recent study [24], 697 SNPs were associated with height in humans at genome-wide
significance, yet these SNPs were able to explain only ∼20% of height variability; ∼9,500 SNPs
were needed to raise that to ∼29%. In addition, ∼ 95% of GWAS variants map to non-coding
regions [3], complicating biological interpretation of their functional impact.
To bridge the functional gap between genetic variant and complex trait, expression Quantitative
Trait Locus (eQTL) analysis associates SNP genotype with gene expression levels. Most eQTL
analyses have focused on cis-SNPs–those near the Transcriptional Start Site (TSS) of the gene in
the association test. Recent computational developments [22] and work demonstrating the impact
and replicability of trans-eQTLs [23, 16] have increased interest in identifying and understanding
the role played by trans-acting SNPs.
However, new methods are needed to elucidate the potential functional impact of the thousands
of GWAS and eQTL SNPs that can be detected in a single study. Here we present a complex
networks method (Fig. 1) that incorporates both cis- and trans- associations to identify groups of
SNPs that are linked to groups of genes and systematically interrogate their biological functions.
We then validate this approach using genotyping and gene expression data from 163 lung tissue
samples in a study of Chronic Obstructive Pulmonary Disease (COPD) by the Lung Genomics
Research Consortium (LGRC).
eQTL Networks
We used the MatrixeQTL package in R to calculate all cis- and trans-eQTLs, considering only
autosomal SNPs, using age, sex, and pack-years as covariates (see Supplementary Methods). The
cis- and trans- associations were run separately, with an FDR threshold of 10%. This analysis
identified 32,053 cis-eQTLs and 39,107 trans-eQTLs. Quantile-quantile plots for both cis- and
trans- are shown in Supplementary Figure S1. In total, 71,160 statistically significant associations
were detected between 54,475 SNPs and 7,091 genes.
We represented these associations as a bipartite network consisting of two classes of nodes—
SNPs and genes—with edges from SNPs to the genes with which they are significantly associated
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based on the eQTL FDR cut-off. The network had a Giant Connected Component (GCC) with
44,872 links, 29,907 SNPs, and 3,390 genes. As a network diagnostic, we plotted the distributions
of edges per SNP–called the SNP degree–and edges per gene (Fig. 2) for the SNPs and genes
in the GCC. The degree distributions for both the SNPs and genes are broad-tailed, implying
potential power-law behavior. To test this, we fit each degree distribution to a power law, and
determined the goodness of fit using the method described in [11] (see Supplementary Methods).
The probability the SNP degree follows a power-law distribution is very low, Ppl ≈ 0, and the gene
degree distribution (Fig. 2b) is also unlikely to be power-law distributed (Ppl < 0.1) even though
there are multiple network hubs, shown in the tail of the distribution in Figure 2b.
It is often cited in complex networks literature that the hubs, those nodes in the network
that are most highly connected, represent critical elements whose removal can disrupt the entire
network [2, 18]. As a result, one widely-held belief about biological networks is that disease-
related elements should be over-represented among the network hubs [4]. To test the hypothesis
that disease-associated SNPs are concentrated in the hubs, we projected GWAS-identified SNPs
associated with a wide range of diseases and phenotypes onto the SNP degree distribution (Fig.
3). We used the gwascat package [8] in R to download GWAS SNPs annotated in the NHGRI
GWAS catalog; 259 of those SNPs mapped to the GCC of the eQTL network. To our surprise, the
network hubs–the right tail of Figure 3–were devoid of disease-associated SNPs which were instead
scattered through the upper left half of the degree distribution. While the SNPs associated with
a single gene are easier to interpret, the concentration of disease-associated SNPs in the middle of
the distribution prompted us to look at other features of the network and its structure.
Community Structure Analysis
Many real-world networks have a complex structure consisting of “communities” of nodes [17].
These communities are often defined as a group of network nodes that are more likely to be
connected to other nodes within their community than they are to those outside of the community.
A widely used measure of community structure is the modularity, which can be interpreted as an
enrichment for links within communities minus an expected enrichment given the network degree
distribution [20].
To partition the nodes from the eQTL network into communities—each of which contains both
SNPs and genes—we maximized the bipartite modularity [5]. As recursive cluster identification and
optimization can be computationally slow, we calculated an initial community structure assignment
on the weighted, gene-space projection, using a fast uni-partite modularity maximization algorithm
[6] available in the R igraph package [14], then iteratively converged (∆Q < 10−4) on a community
structure corresponding to a maximum bipartite modularity.
The bipartite modularity is defined in Eq. (1), where m is the number of links in the network,
A˜ij is the upper right block of the network adjacency matrix (a binary matrix where a 1 represents
a connection between a SNP and a gene and 0 otherwise), ki is the degree of SNP i, dj is the degree
of gene j, and Ci, Cj the community indices of SNP i and gene j, respectively.
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Q =
1
m
∑
i,j
(
A˜ij − kidj
m
)
δ(Ci, Cj) (1)
This analysis identified 35 highly modular communities in the LGRC data (Q = 0.766; Fig. 4).
The density of these communities can be seen in Figure 4. In Figure 4b, there is visible enrichment
for links within each community (colored links) compared to links between different communities
(black links). These communities represent groups of SNPs and genes that are highly connected
to each other, suggesting that groups of genes may be jointly moderated by groups of SNPs that
together represent specific biological processes.
To investigate this hypothesis, we tested each community for GO term enrichment using Fisher’s
Exact Test (available in the R package GOstats [15]) and found 13 of the 35 communities contained
genes enriched for specific Gene Ontology terms (P < 5× 10−4; overlap > 4), encompassing a
broad collection of cellular functions that are not generally associated with COPD. Indeed, this is
what one might expect as the genetic background of an individual should have an effect not only
on disease-specific processes, but more globally on the physiology of his or her individual cells. A
number of communities do, however, show enrichment for biological processes that are known to
be involved in COPD, including genes previously associated with the disease.
For example, Community 18 (see Fig. 4) was enriched for chromatin and nucleosome assem-
bly/organization and includes members of the HIST1H gene superfamily. Community 30 (see Fig.
4) included GO term enrichment for function related to the HLA gene family, including T cell func-
tion and immune response; autoimmunity has been suggested as a potential contributor to COPD
pathogenesis [1]. This community also contains PSORS1C1, which has been previously implicated
in COPD [21].
Another of the genes in Community 30, AGER, has been implicated in COPD [9] and encodes
sRAGE, a biomarker for emphysema. Its expression is negatively associated via eQTL analysis (β =
−0.3) with rs6924102. This SNP has been observed to be an eQTL in a large blood eQTL dataset for
a number of neighboring genes [23], but it has not previously been described as an eQTL for AGER.
This SNP lies in a region containing a DNase peak in cell lines analyzed by ENCODE [12] (indicating
it sits in a region of open chromatin) and there is evidence of POLR2A binding from ChIP-Seq data
in the GM12878 cell line as reported by ENCODE (http://regulomedb.org/snp/chr6/32811382).
This suggests that rs6924102 may inhibit the expression of AGER through disruption of RNA
Polymerase II binding and subsequent mRNA synthesis. This SNP is located ∼700KB from the
well-studied non-synonymous AGER SNP, rs2070600.
Examining Figure 4a, it is evident that within each community there are local hubs that are
highly connected to the genes within that community. To identify these local hubs, we defined a
“core score” that estimates importance of a SNP in the structure of its community. For SNP i in
community h, its core score, Qih, Eq. (2), is the fraction of the modularity of community h, Qh,
Eq. (3), contributed by SNP i. This allows for comparison of SNPs from different communities, as
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each community does not have the same modularity, Qh.
Qih =
1
m
∑
j
(
A˜ij − kidjm
)
δ(Ci, h)δ(Cj , h)
Qh
(2)
Qh =
1
m
∑
i,j
(
A˜ij − kidj
m
)
δ(Ci, h)δ(Cj , h) (3)
If one views disease as the disruption of a process leading to cellular or organismal dysfunction,
one natural hypothesis is that SNPs with the greatest potential to disrupt cellular processes might be
enriched for disease association. To test this we used both the Wilcoxon rank-sum and Kolmogorov-
Smirnov (KS) tests to assay whether the 259 NHGRI GWAS-annotated SNPs in the GCC were more
likely to have high Qih scores. For both tests, the distribution of Qih scores for GWAS-associated
SNPs were compared to the distribution of non-GWAS SNP scores.
To obtain an empirical p-value for these tests, we permuted the GWAS/non-GWAS labels and
recalculated the KS and Wilcoxon tests 105 times. Histograms of the randomized labels are shown
in Figure 5 and (Supplementary Figure S2). The red dot in the histogram represents the test score
with the true labeling. Both tests had highly significant permutation p-values, with P < 10−5 for
the KS and Wilcoxon tests, indicating that GWAS SNPs were over-represented among SNPs with
high core scores. Furthermore, the median core score for the GWAS SNPs was 1.69 times higher
than the median core score for the non-GWAS SNPs. Thus, while global hubs are depleted for
GWAS associations with disease, local hubs are significantly enriched for disease associations.
Discussion
Genome-wide association studies have searched for genomic variants that influence complex traits,
including the development and progression of disease. However, the number of highly-penetrant
Mendelian variants that have been found is surprisingly small, with most disease-associated SNPs
having a weak phenotypic effect. GWAS studies have also identified many SNPs that do not alter
protein coding and have found significant loci that are shared in common across multiple diseases.
This body of evidence suggests that in most instances it is not a single genetic variant that leads to
disease, but many variants of smaller effect that together can disrupt cellular processes that lead
to disease phenotypes. The challenge has been to find these variants of small effect and to place
them into a coherent biological context.
We chose to address this problem by analyzing the link between genetic variants and the most
immediate phenotypic measure, gene expression. In doing so, we chose not to focus solely on cis-
acting SNPs, but also to consider trans-acting variants. Our motivation was, in part, to try to
understand SNPs found through GWAS studies to be associated with phenotypes, but that could
not be immediately placed into a functional context. After performing a genome-wide cis- and
trans- eQTL analysis, we identified a large number of many-to-many associations: single SNPs
associated with many genes as well as single genes that were significantly associated with many
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SNPs. To represent those associations, we constructed a bipartite network, one that contains
two types of nodes—SNPs and genes—with edges connecting SNPs to the genes with which they
were significantly associated. Our analysis of that network led to a number of observations that
independently speak to our intuition about disease and the genetic factors that control it.
First is the observation that the highly connected SNPs, the global hubs in the network, are
devoid of variants that have been identified as being disease-associated in the hundreds of studies
collected in the NHGRI GWAS catalog. While initially surprising, further consideration suggests
that this may be the result of negative selection. Since a true hub SNP influences genes across
the genome that are involved in many biological processes, highly deleterious variants are likely to
significantly disrupt cellular function. In fact, this is the expected impact of a hub—its disruption
should lead to the catastrophic collapse of the network. And so, deleterious SNPs that are network
hubs are likely to be lethal or highly debilitating and therefore strongly selected against and quickly
swept from the genome.
Second, we found that SNPs and their target genes form highly connected communities that
are enriched for specific biological functions. This too speaks to our inituition and to the evidence
about polygenic traits that has accumulated over time. They are not the result of a single SNP that
regulates a single gene, but a family of SNPs that together help mediate a group of functionally-
related genes.
Third, the enrichment for GWAS disease associations among the high Qih SNPs has a very sim-
ple and intuitive interpretation. The SNPs that are most significantly connected within a particular
functionally-related group are those most likely to disrupt that process and therefore be discov-
ered in GWAS analysis. After all, diseases do not develop because the cell’s entire functionality
collapses, but because specific processes within the cell are disrupted.
What our analysis provides is a new way of exploring cis- and trans- eQTL analysis and GWAS.
What one must do is to consider not only the local effects of genetic variants, but also the complex
network of genetic interactions that help regulate phenotypes, including gene expression.
It also suggests a new way of filtering genes for inclusion in GWAS analysis. Since many disease-
associated SNPs appear to be either cis-acting or those which are central to functionally-defined
communities, one should focus on those SNPs most likely perturb specific biological processes rather
than considering the entirety of SNPs in the genome.
As a way of further assessing the link between GWAS significance and functional perturbation
in COPD, we calculated a GWAS-FDR for all SNPs in the GCC of our network that had a reported
p-value from a recent GWAS and meta-analysis of COPD [10] (See Supplemental Methods). There
were 34 SNPs with an FDR < 0.05, and 32 of the 34 had evidence of functional impact according
to RegulomeDB [7], with 16 SNPs identified as likely to affect transcription factor binding and
linked to expression (See Fig. 6). These 34 SNPs mapped to 4 different communities including
Community 30, which contains other COPD-associated SNPs and genes, and is enriched for GO
terms describing T cell function and immune response. One of the SNPs in this community likely to
affect binding is rs9268528, which is linked by our network to HLA-DRA, HLA-DRB4, and HLA-
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DRB5; the cis-eQTL associations between rs9268528 and both HLA-DRA and HLA-DRB5 have
been previously observed in lymphoblastoid cells [19]. All three HLA genes lie in Community 30
and contribute to the community’s enrichment for T cell receptor signaling pathway (GO:0050852)
[13].
To determine the network influence of these 34 SNPs, we compared their core score, Qih (see
Section 2 and Eq. (2)) to the core scores of SNPs with a GWAS-FDR ≥ 0.05 (See Fig. 7). The
median Qih value for the 34 GWAS-FDR significant SNPs was 46.7 times higher than the median
for SNPs with an FDR ≥ 0.05.
One might note that this analysis was carried out using data on genetic variation and gene
expression from the LGRC representing COPD and control lung tissue and question both the
generalizability of the results and the use of GWAS-associated disease SNPs from many diseases
in the analysis. While these are potentially legitimate concerns, many of the community-based
processes we find are not specific to COPD or to the lung but instead are active in nearly all
human cell types.
Although one might expect some processes to change in different disease states, the impact of
common variants and the structure of the network is likely to be highly similar. Consequently,
although there may be some SNPs whose impact is disease and tissue specific, many are likely to
be independent of disease state. This suggests that it may be useful to develop eQTL networks
across disease states and tissue types and to explore changes in the overall network and community
structure across and between phenotypes due to rare variants and tissue-specific expression.
Validating individual associations in the eQTL network is a difficult challenge. Most eQTL
studies limit their validation efforts to downstream effects of high-confidence cis-acting eQTLs.
The bipartite network presented here captures not only these strong cis-eQTLs but also the weak
effects of many more cis- and trans-acting SNPs. So the likelihood that any individual association
can be easily validated may not be that great, as it is likely to be of small phenotypic effect and
important in only a subset of individuals. However, this is not the point. What is important for
the phenotype is not any single SNP-gene association, but the “mesoscale” organization of genes
and SNPs represented by the communities in the network. We believe this intermediate structure
better reflects the aggregation of weak genetic effects that contribute to late-onset complex diseases.
What we hope to have demonstrated in this manuscript is that the higher order structure, which
was not an input to the model, provides insight into a number of aspects of the genetics of polygenic
traits consistent with our understanding of how these traits manifest themselves.
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Figure 1: Summary of the Network Method: All possible SNP-Gene pairs measured in the LGRC
data set are considered in the eQTL analysis. Those SNP-gene pairs that are significantly associated
(FDR < 0.1) are included in the bipartite network. Communities were detected in the network
using a bipartite modularity maximization approach, producing 35 highly modular communities,
13 of which are enriched for various GO terms. GWAS-associated SNPs are much more likely to
lie at the cores of these communities.
3 Supplemental Methods
We began by downloading gene expression data from the LGRC web portal (https://www.lung-genomics.
org/download/) representing data from COPD-case and control samples generated by the Lung Ge-
nomics Research Consortium (LGRC). This included GCRMA-normalized gene expression data
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Figure 2: Plot of the degree distribution, showing the frequency of node degree plotted on a log-log
scale, for SNPs (left) and genes (right) in the giant connected component of the bipartite eQTL
network.
l
l
l
l
l
llll
ll
ll
l
l
l
l
l
l
l
l
l
l
l l
l
ll l
l
ll l
l
l
l
l
ll ll
Degree
Fr
eq
ue
nc
y
SNP Degree Distribution
10
−
4
10
−
3
10
−
2
10
−
1
10
0
100 101 102
l
l
l
l
l
l l
l
l
GWAS SNPs
All SNPs
Figure 3: Degree distributions for NHGRI-GWAS (red) and non-GWAS (black) SNPs. NHGRI-
GWAS SNPs tend not to be network “hubs,” which are located in the far-right tail of the distribu-
tion. The highest degree NHGRI-GWAS SNP was connected to 11 genes.
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Figure 4: (a) Plot of the communities within the bipartite eQTL network. The nodes (genes and
SNPs) in each community form a ring, with the link density within each ring visibly darker than
links between communities. (b) Links within communities (colored points) are shown along the
diagonal, with links that go between communities in black. Community IDs are plotted along the
x-axis.
obtained using Agilent-014850 Whole Human Genome 4x44K and Agilent-028004 SurePrint G3
Human GE 8x60K Microarrays. We then obtained matching genotyping data (dbGAP accession
phs000624.v1.p1) collected using the Illumina Infinium HD Assays with Human Omni 1Quad and
Human Omni 2.5 Quad arrays. All subjects were reported to be of Caucasian descent and were
selected based on a variety of parameters including clinical measures associated with diagnosis.
Samples that did not meet standards for lack of relatedness as measured using Identity by Descent
(IBD) and inbreeding coefficient, F , were excluded. Those samples with discordance between re-
ported and genetic sex were not included. Samples missing more than 10% percent of genotyped
SNPs were also removed. SNPs with minor allele frequency (MAF) < 0.05 or Hardy Weinberg Equi-
librium < 0.001 were removed. After all quality controls, 163 samples remained. The COPD GWAS
data from a meta-analysis of COPDGene non-Hispanic whites and African-Americans, ECLIPSE,
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Figure 5: Histogram of Kolmogorov-Smirnov test statistics comparing the distribution of Qih scores
for sets of randomly relabeled NHGRI-GWAS/non-GWAS SNPs.The KS test statistic for the true
labeling is in red. The permutation p-value associated with the KS test is P < 10−5 given 105
permutations.
GenKOLS, and NETT/NAS studies was obtained from the authors of [10].
3.1 Power-law Fitting
For each empirical degree distribution, we fit the two parameters for a power-law: the minimum
degree at which the power-law behavior starts, dmin, and the exponent, α. A Kolmogorov-Smirnov
test was then used to estimate the goodness of fit between 5,000 randomly generated power-law
distributed synthetic data sets given dmin and α and their corresponding power-law fit. The proba-
bility, Ppl, that a degree distribution follows a power-law with dmin and α is then the fraction
of times a synthetic data set has a KS statistic larger than that of the true test. For both
the SNP and gene degree distributions, Ppl was calculated using the 5,000 goodness of fit val-
ues (code for the parameter estimation, goodness of fit and probability estimation was obtained
from http://tuvalu.santafe.edu/∼aaronc/powerlaws/).
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Regulome DB Scores for COPD GWAS SNPs
1b − eQTL + TF binding + any motif
        + DNase footprint + DNase peak
1d − eQTL + TF binding + any motif
        + DNase peak
1f − eQTL + TF binding/DNase peak
5 − TF binding or DNase peak
6 − Motif hit
7 − no information
Figure 6: Of the 34 SNPs that are eQTLs in the GCC of the LGRC network and also associated
with COPD (FDR < 0.05), 16 are likely to affect transcription factor (TF) binding and linked to
the expression of a target gene (a score of 1b, d, or f), 4 have evidence of TF binding or a DNase
peak (a score of 5), and 12 are located in a motif hit (a score of 6) according to RegulomeDB [7].
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Figure 7: The median core scores for the 34 FDR-significant COPD GWAS SNPs (FDR < 0.05,
left) is 46.7 times higher than the median core score for the non-significant SNPs (FDR ≥ 0.05,
right).
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Figure S1: Quantile-quantile plot for cis- and trans-eQTL associations.
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Figure S2: Histogram of Wilcoxon test statistics comparing the distribution of Qih scores for sets
of randomly relabeled NHGRI-GWAS/non-GWAS SNPs. The Wilcoxon test statistic for the true
labeling is in red. The permutation p-value associated with the Wilcoxon test is P < 10−5 given
105 permutations.
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